I tried to listen, but I found it hard to follow. I assume there was nothing new in the rather dense data "updates" on Telbivudine and Valtorcitabine. I heard but couldn't understand the planned trademark name for valto---did anyone else catch it? Almost off topic, what is J.P. Sommadossi's accent?---I'm guessing a French colony.
Market Data 
Markets 
AI
